Statistical analysis of dose heterogeneity in circulating blood: Implications for sequential methods of total body irradiation

Abstract

Dose heterogeneity in circulating blood cells is clinically acceptable for typical treatment times, perfusion rates, and cell types. Development of conformal, sequential TBI treatment techniques should not be withheld based on concerns over circulating blood dose heterogeneity.